CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESIS
CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESIS
批准号:
7867022
负责人:
CHARLES P. EMERSON
金额:
$1.18万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2010-10-31
关键词:
Biological AssayBirdsCell LineageCell surfaceCellsCloningComplementary DNAComputer AnalysisCultured CellsDevelopmentDiseaseElectroporationEmbryoEnhancersErinaceidaeExtracellular MatrixFamilyFibroblast Growth FactorGene ExpressionGene TargetingGenesGeneticGenetic TranscriptionHomologous GeneInvestigationKnowledgeLeadMaintenanceMapsMediatingMolecularMolecular GeneticsMusMuscleMuscle ProteinsMyoblastsNeural CrestNuclearOrganProcessProtein BiosynthesisProteoglycanRegulationRegulator GenesRegulatory ElementReporter GenesRoleSclerotomeSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSite-Directed MutagenesisSkeletal MuscleSomitesStagingStem cellsSulfatasesSurface EctodermTertiary Protein StructureTestingTissuesTranscriptional ActivationTransfectionTransgenic OrganismsTraumabaseembryo culturegene functiongenetic analysisgenetic regulatory proteinhuman tissuekeratan sulfate proteoglycanmyogenesisnew technologynotochordnovelprogenitorrelating to nervous systemrepairedresearch studyskeletalsomitogenesisstem cell divisiontranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Skeletal muscle provides a unique opportunity to investigate molecular genetic mechanisms that control specification of stem cell
lineages within the cellular complexity of the vertebrate embryo. The proposed studies investigate developmental mechanisms that
regulate the myogenic regulatory genes, MyfS and MyoD, which control the specification of skeletal muscle lineages from somite
progenitors. Experiments focus specifically on the molecular mechanisms by which Sonic hedgehog (Shh) and Wnt signal molecules,
produced by surrounding tissues, induce the transcriptional activation MyfS and MyoD in somitic progenitor cells, and thus initiate
the process of myogenic cell specification. Complementary approaches have been developed to investigate these mechanisms in
mouse and avian embryos. First, MyoD and MyfS transcriptional enhancers will be characterized using transgenic and transfection
reporter gene assays, in combination with site-directed mutagenesis and nuclear factor footprinting, to map regulatory sequences and
identify interacting transcription factors hypothesized to mediate Shh and Wnt induction of MyoD and MyfS.These studies undertake
to distinguish whether the Gli and (3-catenin/LEFtranscription factors, which mediate Shh and Wnt signal transduction, interact
directly with MyoD and MyfS enhancers to control their activation, or alternatively,whether these signals function upstream to
regulate somite-specific transcription factors. Second, the developmental functions of a set of somite-activated regulatory genes,
identified in differential cDNA cloning screens, will be investigated by antisense inhibition and misexpression analyses in avian
embryos and by gene targeting and genetic analyses in the mouse embryo to determine their specific functions in MyoD and MyfS
regulation during somite formation. These studies will focus on a family of two novel Sulfatases that were identified in our screen for
somite-activated genes and are required for activation of MyoD in somites of avian embryos. These Sulfatases are hypothesized to
desulfate proteoglycans in the extracellular matrix, thus controlling the localized activities of developmental signaling molecules
essential for MyoD activation. Other novel somite-activated regulatory genes, identified in these screens, will be investigated to
define their functions in the control of somite formation, Shh signal transduction, and MyoD and MyfS activation. The findings of
these investigations are expected to lead to the discovery of novel developmental regulatory genes that control the specification of
myogenic cells and other lineages in vertebrate embryos. Such knowledge will define fundamentalmechanisms that control of stem
cell formation, and this information will likely lead to the development of new technologies to promote stem cell renewal in the
repair of human tissues and organs damaged by disease and trauma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESIS
-
批准号:8051021
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2010
-
负责人:CHARLES P. EMERSON
-
依托单位:
Identification of inhibitors of hedgehog autoprocessing
-
批准号:8089846
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2009
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:7932575
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2009
-
负责人:CHARLES P. EMERSON
-
依托单位:
Administrative Core - Novel Therapeutics for FSHD
-
批准号:10197167
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8881247
-
项目类别:
-
资助金额:$139.25万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8661472
-
项目类别:
-
资助金额:$108.62万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Pre-clinical Development
-
批准号:10197171
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD - Resources Core - Core C
-
批准号:10197168
-
项目类别:
-
资助金额:$39.56万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Training Core [Parent Title: NOVEL THERAPEUTICS FOR FSHD]
-
批准号:10197172
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8141268
-
项目类别:
-
资助金额:$176.61万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8336877
-
项目类别:
-
资助金额:$65.11万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Genetic Modifiers
-
批准号:10197169
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Genetic Modifiers
-
批准号:10400191
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD
-
批准号:10400188
-
项目类别:
-
资助金额:$154.14万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:7917477
-
项目类别:
-
资助金额:$173.19万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD
-
批准号:10197166
-
项目类别:
-
资助金额:$154.14万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD - Resources Core - Core C
-
批准号:10400190
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Administrative Core - Novel Therapeutics for FSHD
-
批准号:10400189
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Drug Discovery
-
批准号:10400192
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel therapeutics for FSHD
-
批准号:10879926
-
项目类别:
-
资助金额:$74.69万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
海外基金